loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Avanafil

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Avanafil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,201Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hetero Labs V Biologic Avanafil Receives Approval in US
    Hetero Labs V Biologic Avanafil Receives Approval in US

    14 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209266

    FDA
    14 Jun 2024
    Share Share
    Petros Pharma's STENDRA Tablets Reported Improvement in Erectile Function
    Petros Pharma's STENDRA Tablets Reported Improvement in Erectile Function

    08 Sep 2022

    // PRESS RELEASE

    https://feeds.issuerdirect.com/news-release.html?newsid=6687692575178929

    PRESS RELEASE
    08 Sep 2022
    Share Share
    Petros Pharma Announces Positive Results of OTC Label Comprehension Study
    Petros Pharma Announces Positive Results of OTC Label Comprehension Study

    19 Apr 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/04/19/2424598/0/en/Petros-Pharmaceuticals-Announces-Positive-Results-of-Over-the-Counter-OTC-Label-Comprehension-Study-for-Erectile-Dysfunction-Drug-STENDRA-avanafil.html

    GLOBENEWSWIRE
    19 Apr 2022
    Share Share
    Petros Partners with Global Contract Manufacturer for STENDRA's production
    Petros Partners with Global Contract Manufacturer for STENDRA's production

    24 Jan 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/petros-pharmaceuticals-partners-with-leading-global-contract-manufacturer-to-bring-production-of-erectile-dysfunction-drug-stendrao-avanafil-to-the-united-states-301466260.html

    PRNEWSWIRE
    24 Jan 2022
    Share Share
    Petros Pharma Launches Two Self-Selection Studies for STENDRA
    Petros Pharma Launches Two Self-Selection Studies for STENDRA

    18 Jan 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/petros-pharmaceuticals-launches-two-self-selection-studies-for-erectile-dysfunction-drug-stendra-avanafil-301461819.html

    PRNEWSWIRE
    18 Jan 2022
    Share Share
    Petros Pharmaceuticals Reports Q3 Financial Results, Provides Corporate Update
    Petros Pharmaceuticals Reports Q3 Financial Results, Provides Corporate Update

    15 Nov 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/petros-pharmaceuticals-reports-third-quarter-financial-results-and-provides-corporate-update-301424600.html

    PRNEWSWIRE
    15 Nov 2021
    Share Share